# US 2021/0069236 A1 · Prebiotic composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0069236 A1
- Document ID: US20210069236A1
- Status: Published application
- Kind: A1
- Application number: 16/981,355
- Filed: 2019-03-25
- Published: 2021-03-11
- Earliest claimed: 2018-03-23
- Assignees: Institut Polytechnique De Grenoble; Centre National de la Recherche Scientifique (CNRS); Universite Grenoble Alpes; Centre Hospitalier Universitaire Grenoble Alpes
- Applicants: Institut Polytechnique De Grenoble; Centre National De La Recherche Scientifique -Cnrs-; Universite Grenoble Alpes; Centre Hospitalier Universitaire Grenoble Alpes
- Inventors: Christine CHIRAT; Bertrand TOUSSAINT; Vivien DELOULE; Jadwiga CHROBOCZEK; Claire BOISSET-HELBERT
- Web page: https://patentgrep.com/patent/US20210069236A1

## CPC

- A61K 31/736: Glucomannans or galactomannans, e.g. locust bean gum, guar gum
- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61P 1/14: Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The field of the invention is that of prebiotic compositions. In particular, the invention relates to a prebiotic composition comprising galactoglucomannans, and also the production method thereof. The invention also targets the use of this prebiotic composition for increasing production of short-chain fatty acids by bacteria of the intestinal microbiota.

## Claims

### Claim 1

A prebiotic composition comprising galactoglucomannans having a degree of polymerization between 1 and 50, preferably between 1 and 35, and in that it has an acetyl level greater than or equal to 0.1% by mass relative to the total mass of the composition, preferably greater than or equal to 4%, and even more preferably greater than or equal to 6%.

### Claim 2 (depends on 1)

The prebiotic composition according to claim 1, said composition coming from lignocellulosic matter.

### Claim 3 (depends on 1)

The prebiotic composition according to claim 1, said composition coming from one or more types of wood, preferably from one or more resinous types of wood.

### Claim 4 (depends on 1)

The prebiotic composition according to claim 1, wherein the galactoglucomannans concentration is greater than or equal to 20% by mass relative to the total mass of the composition.

### Claim 5 (depends on 1)

The prebiotic composition according to claim 1, said composition further comprising lignin.

### Claim 6 (depends on 1)

The prebiotic composition according to claim 1, said composition promoting the production of short-chain fatty acids in bacteria of the intestinal microbiota.

### Claim 7 (depends on 1)

A process for producing a prebiotic composition according to claim 1, comprising the following steps:
a) autohydrolysis of lignocellulosic materials by thermal treatment in presence of water or steam;
b) purification of the hydrolysate of lignocellulosic materials obtained in step a).

### Claim 8 (depends on 7)

The process according to claim 7, wherein the step a) of autohydrolysis is done at a temperature between 100 and 230° C., preferably between 150 and 180° C. and for a time between 20 minutes and 10 hours, preferably between 30 minutes and 2 hours.

### Claim 9 (depends on 7)

The process according to claim 7, wherein the step b) comprises a phase of processing with activated charcoal and/or a phase of nano- or ultra-filtration and/or a phase of precipitation in a solvent.

### Claim 10 (depends on 7)

The process according to claim 7, wherein the step a) is a step of autohydrolysis of one or more types of wood, preferably one or more resinous types of wood.

### Claim 11 (depends on 1)

A method for increasing the production of short-chain fatty acids by bacteria of the intestinal microbiota, using a prebiotic composition according to claim 1.

### Claim 12

(canceled)

### Claim 13 (depends on 1)

A method for preventing and/or treating inflammatory diseases of the liver, chronic inflammatory diseases of the intestine, systemic chronic inflammatory states, or metabolic imbalances, using a prebiotic composition according to claim 1.
